|Bid price||2.50||Open price||2.63|
|Ask price||2.75||Prev close||2.63|
Register now for FREE live Plethora Solutions Holdings share prices, Plethora Solutions Holdings stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Plethora Solutions Holdings Level 2 Data, indepth research tools and investor commentary for Plethora Solutions Holdings (PLE) and other London Stock Exchange equities.
Register now for FREE Plethora Solutions Holdings share price charts
|Name||Plethora Solutions Holdings||Epic||PLE|
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB00B06GL868|
|Activites||Plethora Solutions Holdings plc is a publicly listed speciality pharmaceutical company with a portfolio of products for the treatment and management of urological disorders. Plethora's mission is to acquire, develop and market (either directly or with partners) products to bring clinical benefit to patients suffering from urological disorders. By fulfilling this mission the Company will build a profitable and sustainable business and yield value growth for shareholders. Plethora's corporate objectives will be realised through: * Licensing or selling rights to Plethora's clinical stage assets in return for milestone and royalty revenue streams ; * Building a profitable and growing, marketing and distribution subsidiary company The Urology Company whose product portfolio will be built by licensing and acquiring rights to products approved for the treatment and management of urological disorders in the UK market.||Index||n/a|
|Latest Share Price (p)||2.63||Net Gearing (%)||61.13|
|Market Capitalisation (£m)||21.65||Gross Gearing (%)||150.27|
|Shares in issue (m)||823.30||Debt Ratio||0.00|
|P/E Ratio||-0.82||Debt-to-Equity Ratio||0.00|
|Total dividends per share (p)||0.00||Assets / Equity Ratio||-1.99|
|Dividend Yield (%)||0.00||Price to book value||-7.57|
|Dividend cover (x)||0.00||ROCE (%)||550.00|
|Earning per share (p)||-3.20||EPS Growth (%)||-23.08|
|52 week high / low||7.75 / 2.13||DPS Growth (%)||n/a|
|Dec.Date||Type||Director||Pos||No. of Shares|
/* */ RNS Number : 6416O Peel Hunt LLP 10 February 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")...
Jim Mellon, Chairman, sold 1,600,000 shares in the company on the 2nd February 2016 at a price of 3.61p. The Director now holds 242,158,261 shares. NOTE: Connected company 200% owned by Mr Mellon Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
/* */ RNS Number : 5620O Plethora Solutions Holdings PLC 09 February 2016 Plethora Solutions Holdings PLC (" Plethora " or the " Company ") Director Shareholding Plethora Solutions Holdings PLC (AIM: PLE) was notified on 8 February 2016 that the...
Register now for FREE Plethora Solutions Holdings company news
Well after all the earlier promises, now slightly overdue and the SMA chart starting to indicate a reversal of fortune I think you might be wise to buy some. Or if you hold some, top up as I've been doing lately. For those not familiar with this stock check on previous news over the last...
any one noticed this for a rise.
Register now for FREE Plethora Solutions Holdings share price discussions